David Gil

636 total citations
21 papers, 300 citations indexed

About

David Gil is a scholar working on Genetics, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, David Gil has authored 21 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Molecular Biology and 5 papers in Clinical Biochemistry. Recurrent topics in David Gil's work include Metabolism and Genetic Disorders (5 papers), Mitochondrial Function and Pathology (4 papers) and Diet and metabolism studies (3 papers). David Gil is often cited by papers focused on Metabolism and Genetic Disorders (5 papers), Mitochondrial Function and Pathology (4 papers) and Diet and metabolism studies (3 papers). David Gil collaborates with scholars based in Spain, Palestinian Territory and United Kingdom. David Gil's co-authors include Javier Blasco‐Alonso, Jaime Dalmau, Rosaura Leis, Enriqueta Román, Dámaso Infante, J. Maldonado, Beatriz Espín, Carlos Sierra, María L. Couce and Félix Sánchez‐Valverde and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nutrients and Medicine.

In The Last Decade

David Gil

20 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Gil Spain 9 115 105 86 84 57 21 300
D. E. M. Francis United Kingdom 11 54 0.5× 122 1.2× 80 0.9× 54 0.6× 61 1.1× 22 304
Marlene W. Borschel United States 10 38 0.3× 43 0.4× 172 2.0× 14 0.2× 39 0.7× 16 310
Shideh Mofidi United States 10 179 1.6× 366 3.5× 23 0.3× 281 3.3× 51 0.9× 16 781
Karl Olof Nilsson Sweden 10 198 1.7× 44 0.4× 16 0.2× 62 0.7× 79 1.4× 16 454
Natalie J. Ronaghan Canada 6 202 1.8× 9 0.1× 34 0.4× 66 0.8× 38 0.7× 10 338
Susanne Hetty Sweden 9 137 1.2× 9 0.1× 21 0.2× 103 1.2× 31 0.5× 22 283
A. Kitamura Japan 3 26 0.2× 13 0.1× 30 0.3× 73 0.9× 29 0.5× 4 341
Azaria Ashkenazi Israel 9 48 0.4× 16 0.2× 170 2.0× 23 0.3× 38 0.7× 10 480
Erin MacLeod United States 12 422 3.7× 616 5.9× 54 0.6× 371 4.4× 73 1.3× 32 807
Daniëlle de Vries Netherlands 8 297 2.6× 138 1.3× 7 0.1× 18 0.2× 20 0.4× 13 495

Countries citing papers authored by David Gil

Since Specialization
Citations

This map shows the geographic impact of David Gil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gil more than expected).

Fields of papers citing papers by David Gil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Gil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gil. The network helps show where David Gil may publish in the future.

Co-authorship network of co-authors of David Gil

This figure shows the co-authorship network connecting the top 25 collaborators of David Gil. A scholar is included among the top collaborators of David Gil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Gil. David Gil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McClatchie, Meriel, Núria Rovira, U. Lohwasser, et al.. (2025). Underutilised crops in Europe: An interdisciplinary approach towards sustainable practices. Archaeometry.
2.
Heras, Javier de las, Javier Blasco‐Alonso, Mafalda Bourbon, et al.. (2024). Practical Recommendations for the Diagnosis and Management of Lysosomal Acid Lipase Deficiency with a Focus on Wolman Disease. Nutrients. 16(24). 4309–4309. 3 indexed citations
3.
Reyes, Susana, et al.. (2024). Simulación clínica pediátrica y encuesta de satisfacción del alumno en el grado de Medicina. Educación Médica. 25(5). 100938–100938. 1 indexed citations
4.
Valenzuela, J. Egea, et al.. (2020). THE ROLE OF ENDOSCOPY IN CAUSTIC INGESTION IN PEDIATRIC POPULATION: EXPERIENCE IN A TERTIARY CENTER. Revista Española de Enfermedades Digestivas. 113(4). 272–275. 3 indexed citations
5.
Sánchez-Siles, Luis Manuel, María José Bernal, David Gil, et al.. (2020). Are Sugar-Reduced and Whole Grain Infant Cereals Sensorially Accepted at Weaning? A Randomized Controlled Cross-Over Trial. Nutrients. 12(6). 1883–1883. 5 indexed citations
6.
Couce, María L., Paula Sánchez‐Pintos, Luis Aldámiz‐Echevarría, et al.. (2019). Evolution of tyrosinemia type 1 disease in patients treated with nitisinone in Spain. Medicine. 98(39). e17303–e17303. 18 indexed citations
7.
Régal, Luc, Isabelle Maystadt, Nicol C. Voermans, et al.. (2017). PREPL deficiency: delineation of the phenotype and development of a functional blood assay. Genetics in Medicine. 20(1). 109–118. 24 indexed citations
8.
Navas‐López, Víctor Manuel, et al.. (2017). Efectividad y seguridad en nuestro entorno de adalimumab como tratamiento anti-TNF de primera linea en niños con enfermedad de Crohn. Anales de Pediatría. 88(2). 89–99. 2 indexed citations
9.
Navas‐López, Víctor Manuel, et al.. (2017). A real-world study focused on the effectiveness and safety of adalimumab as first-line anti-TNF treatment for paediatric Crohn's disease. SHILAP Revista de lepidopterología. 88(2). 89–99. 2 indexed citations
10.
Aldámiz‐Echevarría, Luis, Marta Llarena, Jaime Dalmau, et al.. (2016). Molecular epidemiology, genotype–phenotype correlation and BH4 responsiveness in Spanish patients with phenylketonuria. Journal of Human Genetics. 61(8). 731–744. 29 indexed citations
11.
12.
Aldámiz‐Echevarría, Luis, María L. Couce, Sergio Lage, et al.. (2015). 6R-tetrahydrobiopterin treated PKU patients below 4years of age: Physical outcomes, nutrition and genotype. Molecular Genetics and Metabolism. 115(1). 10–16. 10 indexed citations
13.
Sierra, Carlos, Javier Blasco‐Alonso, Jaime Dalmau, et al.. (2014). Prebiotic effect during the first year of life in healthy infants fed formula containing GOS as the only prebiotic: a multicentre, randomised, double-blind and placebo-controlled trial. European Journal of Nutrition. 54(1). 89–99. 118 indexed citations
14.
Martín‐de‐Carpi, Javier, et al.. (2014). P578 Adalimumab as first-line anti-TNF treatment in pediatric Crohn's disease. Journal of Crohn s and Colitis. 8. S309–S309. 1 indexed citations
15.
Aldámiz‐Echevarría, Luis, María L. Couce, Sergio Lage, et al.. (2013). Tetrahydrobiopterin therapy vs phenylalanine-restricted diet: Impact on growth in PKU. Molecular Genetics and Metabolism. 109(4). 331–338. 23 indexed citations
16.
Aldámiz‐Echevarría, Luis, María L. Couce, Sergio Lage, et al.. (2013). Anthropometric characteristics and nutrition in a cohort of PAH-deficient patients. Clinical Nutrition. 33(4). 702–717. 33 indexed citations
17.
Gil, David, et al.. (2012). Eficacia de un programa de entrenamiento en atención en la esquizofrenia : un estudio piloto = Efficacy of an attention training program in schizophrenia : a pilot study. Revista de Psicopatología y Psicología Clínica. 17(1). 43–43. 1 indexed citations
18.
Gil, David, et al.. (2009). Validez del factor cognitivo de la PANSS como medida del rendimiento cognitivo en esquizofrenia. Revista de Psiquiatría y Salud Mental. 2(4). 160–168. 8 indexed citations
19.
Gil, David, et al.. (2009). Validity of the PANSS cognitive factor as a measurement of cognitive performance in schizophrenia. Revista de Psiquiatría y Salud Mental (English Edition). 2(4). 160–168. 1 indexed citations
20.
Gil, David, et al.. (2004). Encefalitis límbica paraneoplásica y cáncer de pulmón. Anales de Medicina Interna. 21(3). 129–30. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. E. M. Francis Breakdown of academic impact, for papers by Marlene W. Borschel Breakdown of academic impact, for papers by Shideh Mofidi Breakdown of academic impact, for papers by Karl Olof Nilsson Breakdown of academic impact, for papers by Natalie J. Ronaghan Breakdown of academic impact, for papers by Susanne Hetty Breakdown of academic impact, for papers by A. Kitamura Breakdown of academic impact, for papers by Azaria Ashkenazi Breakdown of academic impact, for papers by Erin MacLeod Breakdown of academic impact, for papers by Daniëlle de Vries
Rankless by CCL
2026